Study held to see the effect of Khadiradi pessary in Kaphaja Yonivyapada.

A Single Arm Study Of Khadiradi Pessary In Kaphaja Yonivyapada

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/03/032004

Enrollment

Registered

2021-03-15

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N761- Subacute and chronic vaginitis

Interventions

Intervention1: KHADIRADI PESSARY Dose -3gm Route of Administration- per vaginal duration-7 days x 3 consecutive cycles post mensis: khadir , haritaki, nimba , puga , jatiphala are made into fine powde

Eligibility

Inclusion criteria

Inclusion criteria: married women non pregnant women

Exclusion criteria

Exclusion criteria: pregnancy Sexually transmitted diseases(syphillis , gonorrhea) local skin lesion unmarried cervical erosion and cervicitis post menopausal women cancer of genitalia

Design outcomes

Primary

Measure	Time frame
To evaluate the effect of Khadiradi pessary in Kaphaja yonivyapadaTimepoint: 7 days for 3 consecutive cycles post mensis	—

Secondary

Measure	Time frame
To find out if there are any other outcomes of the same drug like changes in pH of Vagina or effect on the Vaginal floraTimepoint: Post treatment of 7 days after every mensis for 3 cycles of study duration	—

Countries

India

Contacts

Public ContactRumana Abdul Bari Khan

Dr. D.Y. PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE

neetamahesekar19@gmail.com9822627092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026